KR960705038A - 자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease) - Google Patents
자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease)Info
- Publication number
- KR960705038A KR960705038A KR1019960701093A KR19960701093A KR960705038A KR 960705038 A KR960705038 A KR 960705038A KR 1019960701093 A KR1019960701093 A KR 1019960701093A KR 19960701093 A KR19960701093 A KR 19960701093A KR 960705038 A KR960705038 A KR 960705038A
- Authority
- KR
- South Korea
- Prior art keywords
- mog
- peptide
- human
- seq
- fragment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Rehabilitation Therapy (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11682493A | 1993-09-03 | 1993-09-03 | |
US08/116,824 | 1993-09-03 | ||
PCT/US1994/010257 WO1995006727A2 (en) | 1993-09-03 | 1994-09-01 | Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
Publications (1)
Publication Number | Publication Date |
---|---|
KR960705038A true KR960705038A (ko) | 1996-10-09 |
Family
ID=22369451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960701093A KR960705038A (ko) | 1993-09-03 | 1994-09-01 | 자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease) |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0716696A1 (ja) |
JP (1) | JPH09502346A (ja) |
KR (1) | KR960705038A (ja) |
AU (1) | AU7725894A (ja) |
CA (1) | CA2170901A1 (ja) |
FI (1) | FI961000A (ja) |
NO (1) | NO960858D0 (ja) |
NZ (1) | NZ273813A (ja) |
WO (1) | WO1995006727A2 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10504039A (ja) * | 1994-10-25 | 1998-04-14 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | 多発性硬化症のための組成物および治療法 |
AU5565896A (en) * | 1995-05-02 | 1996-11-21 | Alexion Pharmaceuticals, Inc. | Modified myelin protein molecules |
CA2250361A1 (en) * | 1996-03-28 | 1997-10-02 | Barbara Wallner | Myelin oligodendrocyte glycoprotein peptides and uses thereof |
WO1998033912A1 (en) * | 1997-01-30 | 1998-08-06 | Human Genome Sciences, Inc. | MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE |
SE9703287D0 (sv) * | 1997-09-11 | 1997-09-11 | Astra Ab | Peptides |
ZA9810133B (en) * | 1997-11-07 | 1999-05-17 | Biogen Inc | BMOG a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for ummonomodulatory purposes |
US6333033B1 (en) * | 1998-08-26 | 2001-12-25 | The Regents Of The University Of California | Autoantibody inhibitors |
CN1301756A (zh) * | 1999-12-29 | 2001-07-04 | 复旦大学 | 一种新的多肽——髓磷脂p0蛋白14和编码这种多肽的多核苷酸 |
CN1352087A (zh) * | 2000-11-02 | 2002-06-05 | 上海博德基因开发有限公司 | 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸 |
WO2007008933A2 (en) * | 2005-07-11 | 2007-01-18 | Carantech Biosciences, Inc. | Compositions and methods comprising complex alternative splice variants of myelin/oligodendrocyte genes (mogs) and antibodies directed thereto |
CN101897964B (zh) * | 2009-04-27 | 2013-04-10 | 中国农业大学 | 一种预防自身免疫疾病的药物 |
WO2013020914A1 (en) * | 2011-08-10 | 2013-02-14 | Celares Gmbh | Peg-conjugated peptides |
GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
AU2015249328B2 (en) * | 2014-04-24 | 2019-01-17 | University Of Florida Research Foundation, Inc. | AAV-based gene therapy for multiple sclerosis |
CA3048601A1 (en) * | 2016-12-26 | 2018-07-05 | Kyowa Hakko Kirin Co., Ltd. | Antibody which binds to myelin oligodendrocyte glycoprotein |
US11334352B1 (en) | 2020-12-29 | 2022-05-17 | Kpn Innovations, Llc. | Systems and methods for generating an immune protocol for identifying and reversing immune disease |
-
1994
- 1994-09-01 WO PCT/US1994/010257 patent/WO1995006727A2/en not_active Application Discontinuation
- 1994-09-01 NZ NZ273813A patent/NZ273813A/en unknown
- 1994-09-01 JP JP7508328A patent/JPH09502346A/ja active Pending
- 1994-09-01 CA CA002170901A patent/CA2170901A1/en not_active Abandoned
- 1994-09-01 EP EP94928084A patent/EP0716696A1/en not_active Withdrawn
- 1994-09-01 KR KR1019960701093A patent/KR960705038A/ko not_active Application Discontinuation
- 1994-09-01 AU AU77258/94A patent/AU7725894A/en not_active Abandoned
-
1996
- 1996-03-01 NO NO960858A patent/NO960858D0/no unknown
- 1996-03-04 FI FI961000A patent/FI961000A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
NO960858L (no) | 1996-03-01 |
EP0716696A1 (en) | 1996-06-19 |
NZ273813A (en) | 1998-05-27 |
WO1995006727A3 (en) | 1995-04-13 |
FI961000A0 (fi) | 1996-03-04 |
WO1995006727A2 (en) | 1995-03-09 |
AU7725894A (en) | 1995-03-22 |
FI961000A (fi) | 1996-03-04 |
CA2170901A1 (en) | 1995-03-09 |
NO960858D0 (no) | 1996-03-01 |
JPH09502346A (ja) | 1997-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960705038A (ko) | 자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease) | |
Jacob et al. | Binding of a monoclonal anti-DNA autoantibody to identical protein (s) present at the surface of several human cell types involved in lupus pathogenesis. | |
Martin et al. | A metabolite of halothane covalently binds to an endoplasmic reticulum protein that is highly homologous to phosphatidylinositol-specific phospholipase C-α but has no activity | |
EP0728146B1 (en) | Conotoxin peptides | |
Kaul et al. | Amino acid sequence of the N alpha-terminal 201 residues of human erythrocyte membrane band 3. | |
KR960706560A (ko) | 인화 항체 및 이것의 사용 방법(humanized antibodies and uses thereof) | |
KR950032279A (ko) | 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna) | |
RU2432360C2 (ru) | Вариант еро, обладающий повышенным сродством связывания с рецептором и сниженным антигенным потенциалом, днк, кодирующая такой вариант еро, рекомбинантный экспрессионный вектор, содержащий такую днк, клетка-хозяин, трансформированная или трансфектированная таким вектором, способ получения такого варианта еро и фармацевтическая композиция, содержащая такой вариант еро | |
Lorenz et al. | T cell recognition of bovine ribonuclease. Self/non-self discrimination at the level of binding to the I-Ak molecule. | |
RU2178797C2 (ru) | Новые пептиды, являющиеся производными аутоантигена, предназначенные для использования в иммунотерапии аутоиммунных заболеваний | |
US5633347A (en) | Conotoxin peptides | |
US5595972A (en) | Conotoxin peptides | |
CA2092541A1 (en) | Antagonists of human gamma interferon | |
DE3584775D1 (de) | Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken. | |
Chatterjee et al. | Homology of adenoviral E3 glycoprotein with HLA-DR heavy chain. | |
KR920012440A (ko) | 인간 인터류킨-5 수용체 | |
DE69607034D1 (de) | Pcna bindende substanz | |
KR960705583A (ko) | Mhc 단백질의 원핵세포내 형질발현(prokaryotic expression of mhc proteins) | |
Cunningham et al. | Structure of murine histocompatibility antigens | |
US5589340A (en) | Process and primers for identifying nucleic acids encoding A-lineage conotoxin peptides | |
Imamura et al. | A novel nonmuscle alpha-actinin. Purification and characterization of chicken lung alpha-actinin. | |
Kefalides et al. | Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen | |
Babe et al. | Epitopes on the major capsid protein of simian virus 40 | |
KR930703444A (ko) | 어류 황체화 호르몬-방출 호르몬 동족체 | |
Ametani et al. | Antibody response of three different strains of mice to αs1-casein analyzed by using proteolytic and synthetic peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |